HSA
DXCM icon

HBK Sorce Advisory’s DexCom DXCM Stock Holding History

HBK Sorce Advisory’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,459
Closed -$229K – 578
2023
Q3 		$229K Sell
2,459
-526
-18% -$59.3K 0.01% 491
2023
Q2 		$384K Buy
2,985
+16
+0.5% +$1.94K 0.02% 387
2023
Q1 		$345K Sell
2,969
-4,057
-58% -$454K 0.02% 405
2022
Q4 		$795K Buy
7,026
+2,991
+74% +$328K 0.02% 333
2022
Q3 		$325K Buy
4,035
+1,204
+43% +$102K 0.02% 346
2022
Q2 		$211K Sell
2,831
-1,345
-32% -$123K 0.02% 414
2022
Q1 		$534K Buy
4,176
+592
+17% +$64.8K 0.03% 299
2021
Q4 		$481K Buy
3,584
+160
+5% +$23K 0.02% 340
2021
Q3 		$468K Sell
3,424
-260
-7% -$32.8K 0.03% 330
2021
Q2 		$393K Buy
3,684
+92
+3% +$8.84K 0.02% 378
2021
Q1 		$323K Buy
3,592
+112
+3% +$10.5K 0.02% 384
2020
Q4 		$322K Buy
3,480
+552
+19% +$49.3K 0.02% 359
2020
Q3 		$302K Buy
2,928
+856
+41% +$89.4K 0.02% 349
2020
Q2 		$210K Buy
+2,072
New +$185K 0.02% 399

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

HBK Sorce Advisory's DXCM Position: Q4 2023 in Review

HBK Sorce Advisory sold out of DexCom (DXCM) in Q4 2023, closing a stake of 2,459 shares — an estimated $229K sold.

HBK Sorce Advisory first reported a position in DXCM in Q2 2020 and held it in 14 quarters. The position peaked at $795K in Q4 2022. 974 funds tracked by Wall St. Rank hold DXCM as of Q4 2023.

  • HBK Sorce Advisory reported no remaining DexCom position as of Q4 2023 after selling out during the quarter.
  • HBK Sorce Advisory sold 2,459 DexCom shares in Q4 2023, an estimated $229K.
  • HBK Sorce Advisory first reported a position in DexCom in Q2 2020 and held it in 14 quarters.
  • HBK Sorce Advisory's DexCom position peaked at $795K in Q4 2022.
  • 974 funds tracked by Wall St. Rank held DexCom as of Q4 2023.

Based on HBK Sorce Advisory's 13F filing for Q4 2023, filed 25 Jan 2024.